The pharma major is also strengthening its presence in the central nervous system (CNS) therapeutic area, Vohra stated ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Cipla is preparing to enter the weight-loss drug making sector, heating the competition with US-based Eli Lilly & Co and Danish firm Novo Nordisk.

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss ...

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

One in eight Americans use GLP-1 weight-loss drugs, but are they getting the real thing? Novo Nordisk's dramatic exit from a ...

Experts are warning anyone experiencing GLP-1 drug side effects to report them after launching an investigation into their safety.

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

The expert has revealed why the GLP-1 medication could be playing a role in the bedroom and paving the way for divorce in ...

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...